Found: 6
Select item for more details and to access through your institution.
Possibility of pharmacokinetic drug interaction between a DPP-4 inhibitor and a SGLT2 inhibitor.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 1, p. 17, doi. 10.12793/tcp.2020.28.e4
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 1, p. 43, doi. 10.12793/tcp.2020.28.e2
- By:
- Publication type:
- Article
Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 1, p. 55, doi. 10.12793/tcp.2020.28.e5
- By:
- Publication type:
- Article
What is the optimal fit-for-purpose design in an oncology first-in-human trial?: 3+3 vs. Bayesian Logistic Regression Model.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 1, p. 1, doi. 10.12793/tcp.2020.28.e1
- By:
- Publication type:
- Article
Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 1, p. 34, doi. 10.12793/tcp.2020.28.e6
- By:
- Publication type:
- Article
Complex influences of gut microbiome metabolism on various drug responses.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 1, p. 7, doi. 10.12793/tcp.2020.28.e3
- By:
- Publication type:
- Article